$SGMO SANGAMO THERAPEUTICS, INC Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in SANGAMO THERAPEUTICS, INC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in SANGAMO THERAPEUTICS, INC. Insider overview, share value development, latest insider transactions and email notifications about new events in SANGAMO THERAPEUTICS, INC for free.

CIK Number: 0001001233
IRS Number: 680359556
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: SGMO
Company Address: 7000 MARINA BLVD BRISBANE 94005
Former name: SANGAMO BIOSCIENCES INC, date of change: 2000-02-08

Sangamo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the research and development of zinc finger proteins. It focuses on three therapeutic areas: inherited metabolic diseases, central nervous system, and diseases and immunology, which comprises inflammatory and autoimmune diseases. It also offers complementary technology platforms such as gene therapy, ex vivo cell therapy, in vivo genome editing, and in vivo genome regulation. The company was founded by Edward O. Lanphier II in 1995 and is headquartered in Brisbane, CA.

Market Capitalization: $254.24M
Prev close: $3.85
Average Daily Volume: 923,424
Days Low: $3.55
Year Low: $2.65
Year High: $7.60

SANGAMO THERAPEUTICS, INC Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
Boissel StephaneEVP, Corp. Strategy85,023327,339shares bought: 113,451 / shares sold: -43,335 STRONG BUYJul 31 20208 days ago
Carey RobertDirector7,50028,875shares bought: 7,500 / shares sold: 0 STRONG BUYMay 20 20203 months ago
DILLY STEPHEN GEORGEDirector7,50028,875shares bought: 57,500 / shares sold: -50,000 BUYMay 20 20203 months ago
McClung David MarkEVP, Chief Business Officer100,000385,000shares bought: 200,000 / shares sold: 0 STRONG BUYJun 29 20201 month ago
Meyers James RDirector7,50028,875shares bought: 7,500 / shares sold: 0 STRONG BUYMay 20 20203 months ago
PARKER H STEWARTDirector15,50059,675shares bought: 14,500 / shares sold: 0 STRONG BUYMay 20 20203 months ago
Ramasastry SairaDirector7,50028,875shares bought: 21,950 / shares sold: -14,450 BUYMay 20 20203 months ago
Smith Karen L.Director10,00038,500shares bought: 10,000 / shares sold: 0 STRONG BUYMay 20 20203 months ago
Zakrzewski Joseph SDirector32,500125,125shares bought: 32,500 / shares sold: 0 STRONG BUYMay 20 20203 months ago

View all SANGAMO THERAPEUTICS, INC insiders.

SANGAMO THERAPEUTICS, INC Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jul 31 2020SGMOSANGAMO THERAPEUTI ...Boissel StephaneEVP, Corp. StrategyOption ExerciseE0.00101
Jul 31 2020SGMOSANGAMO THERAPEUTI ...Boissel StephaneEVP, Corp. StrategyOption ExerciseE0.00102
Jun 29 2020SGMOSANGAMO THERAPEUTI ...McClung David MarkEVP, Chief Business ...Option ExerciseA9.16200,0001,832,000200,000
Jun 29 2020SGMOSANGAMO THERAPEUTI ...McClung David MarkEVP, Chief Business ...GrantA0.00100,0000100,0000 to 100 K
Jun 05 2020SGMOSANGAMO THERAPEUTI ...Boissel StephaneEVP, Corp. StrategyOption ExerciseM2.09122
Jun 05 2020SGMOSANGAMO THERAPEUTI ...Boissel StephaneEVP, Corp. StrategySellD11.2314,907167,40670,11685 K to 70.1 K (-17.53 %)
Jun 05 2020SGMOSANGAMO THERAPEUTI ...Boissel StephaneEVP, Corp. StrategyBuyM0.0014,907085,02370.1 K to 85 K (+21.26 %)
Jun 05 2020SGMOSANGAMO THERAPEUTI ...Boissel StephaneEVP, Corp. StrategyOption ExerciseM2.09122
Jun 05 2020SGMOSANGAMO THERAPEUTI ...Boissel StephaneEVP, Corp. StrategySellD11.2314,907167,40670,11685 K to 70.1 K (-17.53 %)
Jun 05 2020SGMOSANGAMO THERAPEUTI ...Boissel StephaneEVP, Corp. StrategyBuyM0.0014,907085,02370.1 K to 85 K (+21.26 %)
May 20 2020SGMOSANGAMO THERAPEUTI ...Zakrzewski Joseph SDirectorOption ExerciseA10.4615,000156,90015,000
May 20 2020SGMOSANGAMO THERAPEUTI ...Zakrzewski Joseph SDirectorGrantA0.002,500032,50030 K to 32.5 K (+8.33 %)
May 20 2020SGMOSANGAMO THERAPEUTI ...Smith Karen L.DirectorOption ExerciseA10.4615,000156,90015,000
May 20 2020SGMOSANGAMO THERAPEUTI ...Smith Karen L.DirectorGrantA0.002,500010,0007.5 K to 10 K (+33.33 %)
May 20 2020SGMOSANGAMO THERAPEUTI ...Ramasastry SairaDirectorOption ExerciseA10.4615,000156,90015,000

View all SANGAMO THERAPEUTICS, INC insider transactions.